The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:The Trendlines Group Ltd (42T) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11506
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and other marketing communications services to entrepreneurs. It collaborates and partners with entrepreneurs, investors, strategic players, inventors, governments, agricultural experts and research centers in Israel to improve human conditions and to solve the global food crisis. The company prefers to exit its investments through merger and acquisition transactions. Trendlines is headquartered in Tiberias, Israel.

The Trendlines Group Ltd (42T) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Trendlines Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Trendlines Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Trendlines Acquires Intellectual Property from Endo 11
Venture Financing 12
ElastiMed Raises USD1 Million in Financing Round 12
Acquisition 13
Arkin Bio Ventures Acquires 3.18% Stake in Biosight from Trendlines Group 13
The Trendlines Group Ltd – Key Competitors 14
The Trendlines Group Ltd – Key Employees 15
The Trendlines Group Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Feb 23, 2017: Trendlines Medical Singapore Launches 17
Financial Announcements 18
May 09, 2018: The Trendlines Group Reports 2018 First Quarter Results 18
Feb 22, 2017: The Trendlines Group Reports 2016 Year-End Results 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Trendlines Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Trendlines Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
The Trendlines Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Trendlines Acquires Intellectual Property from Endo 11
ElastiMed Raises USD1 Million in Financing Round 12
Arkin Bio Ventures Acquires 3.18% Stake in Biosight from Trendlines Group 13
The Trendlines Group Ltd, Key Competitors 14
The Trendlines Group Ltd, Key Employees 15
The Trendlines Group Ltd, Other Locations 16
The Trendlines Group Ltd, Subsidiaries 16

List of Figures
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Trendlines Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corporacion Electrica Nacional SA:企業の戦略的SWOT分析
    Corporacion Electrica Nacional SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline product portfolio includes drugs for various indications such as endometriosis; male hypogonadism and antiandrogens, among others. …
  • curasan AG (CUR):企業の財務・戦略的SWOT分析
    curasan AG (CUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Spire Inc (SR):石油・ガス:M&Aディール及び事業提携情報
    Summary Spire Inc (Spire), formerly Laclede Group, Inc., is a public utility, which carries out the sale, marketing and retail distribution of natural gas. It also markets natural gas and related activities on a non-regulated basis. The company also conducts transportation of liquid propane; real es …
  • Alfa Wassermann SpA-製薬・医療分野:企業M&A・提携分析
    Summary Alfa Wassermann SpA (Alfa Wassermann), a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company o …
  • Rad Source Technologies Inc:企業の戦略的SWOT分析
    Rad Source Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Peter MacCallum Cancer Centre:製薬・医療:M&Aディール及び事業提携情報
    Summary Peter MacCallum Cancer Centre (Peter Mac) is a provider of public health services. It serves as a cancer research, treatment and education centre. The centre provides wide range of services including diagnostic, radiation therapy, treatment, cancer information and support services. It works …
  • Heidelberger Druckmaschinen AG (HDD):企業の財務・戦略的SWOT分析
    Heidelberger Druckmaschinen AG (HDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Senvion SA:企業の戦略的SWOT分析
    Senvion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Toyo Seikan Group Holdings, Ltd.:企業の戦略・SWOT・財務情報
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Hyperstone GmbH:企業の戦略的SWOT分析
    Hyperstone GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Territorial Generating Company #2 (TGKB):企業の財務・戦略的SWOT分析
    Territorial Generating Company #2 (TGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Pure Technologies Ltd:企業の戦略的SWOT分析
    Pure Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務情報
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • HSBC Trinkaus & Burkhardt AG (TUB):企業の財務・戦略的SWOT分析
    HSBC Trinkaus & Burkhardt AG (TUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ConAgra Brands Inc:企業のM&A・事業提携・投資動向
    ConAgra Brands Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ConAgra Brands Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • ANGLE plc (AGL):企業の製品パイプライン分析2018
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Shimadzu Corp (7701):医療機器:M&Aディール及び事業提携情報
    Summary Shimadzu Corp (Shimadzu) is a manufacturer of precision instruments, measuring instruments and medical equipment. The company’s product portfolio includes high performance liquid chromatographs (HPLC), spectrometers, carbon analyzer, X-ray systems, inspection systems, semiconductor manufactu …
  • Allergan Plc (AGN):企業の財務・戦略的SWOT分析
    Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆